Annual long term liabilities:
$333.14M+$332.56M(+56556.97%)Summary
- As of today (September 16, 2025), SNDX annual total long term liabilities is $333.14 million, with the most recent change of +$332.56 million (+56556.97%) on December 31, 2024.
- During the last 3 years, SNDX annual long term liabilities has risen by +$312.54 million (+1516.73%).
- SNDX annual long term liabilities is now at all-time high.
Performance
SNDX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$325.74M-$5.36M(-1.62%)Summary
- As of today (September 16, 2025), SNDX quarterly total long term liabilities is $325.74 million, with the most recent change of -$5.36 million (-1.62%) on June 30, 2025.
- Over the past year, SNDX quarterly long term liabilities has increased by +$325.60 million (+237664.96%).
- SNDX quarterly long term liabilities is now -2.22% below its all-time high of $333.14 million, reached on December 31, 2024.
Performance
SNDX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SNDX Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10000.0% | +10000.0% |
3 y3 years | +1516.7% | +2300.1% |
5 y5 years | +2357.3% | +901.8% |
SNDX Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | -2.2% | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | -2.2% | >+9999.0% |
alltime | all time | at high | >+9999.0% | -2.2% | >+9999.0% |
SNDX Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $325.74M(-1.6%) |
Mar 2025 | - | $331.10M(-0.6%) |
Dec 2024 | $333.14M(>+9900.0%) | $333.14M(>+9900.0%) |
Sep 2024 | - | $2000.00(-98.5%) |
Jun 2024 | - | $137.00K(-59.0%) |
Mar 2024 | - | $334.00K(-43.2%) |
Dec 2023 | $588.00K(-18.6%) | $588.00K(-31.9%) |
Sep 2023 | - | $864.00K(-23.6%) |
Jun 2023 | - | $1.13M(+88.5%) |
Mar 2023 | - | $600.00K(-16.9%) |
Dec 2022 | $722.00K(-96.5%) | $722.00K(-7.7%) |
Sep 2022 | - | $782.00K(-94.2%) |
Jun 2022 | - | $13.57M(-20.7%) |
Mar 2022 | - | $17.12M(-16.9%) |
Dec 2021 | $20.61M(-30.3%) | $20.61M(+74.8%) |
Sep 2021 | - | $11.79M(-51.3%) |
Jun 2021 | - | $24.20M(-10.0%) |
Mar 2021 | - | $26.90M(-9.0%) |
Dec 2020 | $29.55M(+118.0%) | $29.55M(-8.1%) |
Sep 2020 | - | $32.17M(-1.0%) |
Jun 2020 | - | $32.51M(-1.0%) |
Mar 2020 | - | $32.86M(+142.4%) |
Dec 2019 | $13.56M | $13.56M(-3.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $14.04M(-4.0%) |
Jun 2019 | - | $14.62M(-3.2%) |
Mar 2019 | - | $15.11M(+2.2%) |
Dec 2018 | $14.79M(-13.4%) | $14.79M(-2.6%) |
Sep 2018 | - | $15.18M(-3.5%) |
Jun 2018 | - | $15.72M(-2.4%) |
Mar 2018 | - | $16.10M(-5.7%) |
Dec 2017 | $17.07M(+17.7%) | $17.07M(+25.8%) |
Sep 2017 | - | $13.57M(-1.8%) |
Jun 2017 | - | $13.82M(-1.7%) |
Mar 2017 | - | $14.06M(-3.1%) |
Dec 2016 | $14.51M(-21.0%) | $14.51M(-1.6%) |
Sep 2016 | - | $14.75M(-2.1%) |
Jun 2016 | - | $15.06M(-2.1%) |
Mar 2016 | - | $15.38M(+193.3%) |
Dec 2015 | $18.36M(+124.3%) | - |
Dec 2014 | $8.19M(+229.8%) | - |
Sep 2014 | - | $5.24M(+620.2%) |
Jun 2014 | - | $728.00K(-71.6%) |
Mar 2014 | - | $2.57M(+3.4%) |
Dec 2013 | $2.48M(-56.4%) | $2.48M(>+9900.0%) |
Sep 2013 | - | $0.00 |
Dec 2012 | $5.69M(-45.4%) | - |
Dec 2011 | $10.44M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of SNDX is $333.14M
What is the all time high annual long term liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual total long term liabilities is $333.14M
What is Syndax Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, SNDX annual total long term liabilities has changed by +$332.56M (+56556.97%)
What is Syndax Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of SNDX is $325.74M
What is the all time high quarterly long term liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $333.14M
What is Syndax Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, SNDX quarterly total long term liabilities has changed by +$325.60M (+237664.96%)